Amnean Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 6.86 Cr
as on 17-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 17-12-2024
- Revenue 877.70%
(FY 2022)
- Profit -3.89%
(FY 2022)
- Ebitda -29.54%
(FY 2022)
- Net Worth -1123.51%
(FY 2022)
- Total Assets 5.95%
(FY 2022)
About Amnean Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.86 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Venkateswara Srikonda, Sharada Pochampally, Mahaboob Shaik, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2012PTC081046
- Company No.
081046
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Mahabub Nagar, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Amnean Therapeutics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Bangalore  | Director | 21-May-2012 | Current |
Venkateswara Srikonda  | Director | 21-May-2012 | Current |
| Sharada Pochampally | Director | 20-Aug-2012 | Current |
| Mahaboob Shaik | Director | 20-Aug-2012 | Current |
Financial Performance of Amnean Therapeutics.
Amnean Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 877.7% increase. The company also saw a slight decrease in profitability, with a 3.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1123.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amnean Therapeutics?
In 2022, Amnean Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Aug 2016 | ₹5.00 Cr | Open |
How Many Employees Work at Amnean Therapeutics?
Unlock and access historical data on people associated with Amnean Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amnean Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amnean Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
